Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

1.870 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.870
Bid (Size) 1.900 (11)
Ask (Size) 2.370 (2)
Prev. Close 1.870
Today's Range 1.870 - 1.870
52wk Range 1.750 - 14.67
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Via ACCESS Newswire
Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain
Via ACCESS Newswire

Performance

YTD
-77.3%
-77.3%
1 Month
-61.3%
-61.3%
3 Month
-76.4%
-76.4%
6 Month
-30.7%
-30.7%
1 Year
-84.0%
-84.0%

More News

Read More
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results
Via ACCESS Newswire
Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment
Via ACCESS Newswire
Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
Via ACCESS Newswire
Ensysce Biosciences Issues Annual Shareholder Letter
Via ACCESSWIRE
Ensysce Biosciences to Participate in the 37th Annual ROTH Conference
Via ACCESS Newswire
Ensysce Biosciences Regains Full Compliance with Nasdaq
Via ACCESSWIRE
Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
Via ACCESSWIRE
Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR
Via ACCESSWIRE
Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial
Via ACCESSWIRE
Ensysce Biosciences Reports Third Quarter 2024 Financial Results
Via ACCESSWIRE
Ensysce Biosciences Announces 1-for-15 Reverse Stock Split
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Surges Over 150 Points; Alphabet Posts Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Ensysce Biosciences, Inc. - Common Stock publicly traded?
Yes, Ensysce Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Ensysce Biosciences, Inc. - Common Stock trade on?
Ensysce Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ensysce Biosciences, Inc. - Common Stock?
The ticker symbol for Ensysce Biosciences, Inc. - Common Stock is ENSC on the Nasdaq Stock Market
What is the current price of Ensysce Biosciences, Inc. - Common Stock?
The current price of Ensysce Biosciences, Inc. - Common Stock is 1.870
When was Ensysce Biosciences, Inc. - Common Stock last traded?
The last trade of Ensysce Biosciences, Inc. - Common Stock was at 04/09/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.